Roger Rönn

Roger Rönn is a Researcher at Lund University’s Faculty of Medicine, affiliated with the Division of Molecular Medicine and Gene Therapy and the national initiative StemTherapy. His work focuses on stem cell biology and regenerative medicine, particularly in hematopoietic development from pluripotent stem cells.

• Key Research Themes: Hematopoietic stem cells, retinoic acid signaling, CD90+ progenitors, cyclic AMP modulation, endothelial-to-hematopoietic transition, and stromal cell applications.

Published works (2015–2023) demonstrate expertise in stem cell differentiation protocols, oxidative stress mitigation, and retinoid pathway regulation. Articles frequently address challenges in generating functional hematopoietic cells for therapeutic use, with methods involving Epac axis activation and hemogenic endothelium manipulation. Citations and patent references reflect translational impact.

His research intersects with UN Sustainable Development Goals (SDG3: Good Health and Well-being; SDG9: Industry Innovation) through advancements in cell therapy and regenerative medicine. Collaborations with Woods, Parmar, and Sitnicka are evident, with works widely disseminated via social media (340+ X posts) and 22 patents citing his research.